Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder

Personalizing treatment for late-life depression requires identifying and integrating information from multiple factors that influence treatment efficacy (moderators). We performed exploratory moderator analyses using data from a multi-site, randomized, placebo-controlled, double-blind trial of arip...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Psychiatr Res
Huvudupphovsmän: Smagula, Stephen F., Wallace, Meredith L., Anderson, Stewart J., Karp, Jordan F., Lenze, Eric J., Mulsant, Benoit H., Butters, Meryl A., Blumberger, Daniel M., Diniz, Breno S., Lotrich, Francis, Dew, Mary Amanda, Reynolds, Charles F.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021594/
https://ncbi.nlm.nih.gov/pubmed/27438687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2016.07.005
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk